Diabetes drug tested as potential depression booster
NCT ID NCT06707012
Summary
This study is testing whether adding the diabetes medication metformin to standard antidepressant treatment helps reduce depression symptoms in obese adults who don't have diabetes. Researchers will compare 140 participants who receive either metformin or a placebo pill alongside their regular depression treatment over 36 weeks. The main goal is to see if the metformin group shows greater improvement in depression scores and certain body chemistry markers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fazaia Rurh Pfau Medical College
RECRUITINGKarachi, Sindh, 75120, Pakistan
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
-
Fazaia Ruth Pfau Medical College
RECRUITINGKarachi, Sindh, 75120, Pakistan
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.